Eric Winer, MD, Smilow Cancer Hospital physician-in-chief and director of Yale Cancer Center, presented the opening session, “Partnering with Patients,” at the American Society of Clinical Oncology (ASCO) meeting in June. Dr. Winer served as the 2022-2023 ASCO president. Also at the conference, Roy Herbst, MD, PhD, chief of Medical Oncology, Smilow Cancer Hospital and Yale Cancer Center, presented groundbreaking findings from the ADAURA clinical trial. The trial showed improved survival rates and less risk of recurrence in patients with non-small cell lung cancer and a EGFR mutation who took osimertinib (TAGRISSO), a targeted therapy, following surgery. Dr. Herbst is also deputy director of Yale Cancer Center and director, Center for Thoracic Cancers, Smilow Cancer Hospital and Yale Cancer Center.
